Associations of anti-Smith antibo dies with clinical manifestations and disease activity in children with systemic lupus erythematosns
10.3760/cma.j.issn.0412-4030.2013.09.017
- VernacularTitle:血清抗Sm抗体与儿童系统性红斑狼疮临床表现与疾病活动性相关分析
- Author:
Jieqiu ZHUANG
;
Fangxuan CHEN
;
Wanwan JIN
;
Qing YANG
;
Yu GAO
- Publication Type:Journal Article
- From:
Chinese Journal of Dermatology
2013;46(9):667-669
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the associations of anti-Smith antibodies with clinical manifestations and disease activity in children with systemic lupus erythematosus (SLE).Methods According to SLE disease activity index (SLEDAI) score,72 children with SLE were divided into the active group and inactive group.An immunoblotting method was used to detect serum anti-Smith antibodies in these subjects.Chi-square test was conducted to assess the associations of anti-Smith antibodies with clinical manifestations and disease activity in these patients.Results Of these patients,28 (38.9％) were assigned into the inactive group,and 44 (61.1％) to the active group.Anti-Smith antibodies were detected in 17 (23.6％) patients,but not in the other 55 (76.4％) patients.Elevated incidence rate of kidney injury was observed in anti-Smith antibody-positive patients compared with anti-Smith antibody-negative patients (70.6％ (12/17) vs.41.8％ (23/55),P ＜ 0.05).Meanwhile,the positivity rate of anti-Smith antibodies was 31.8％ (14/44) in the active group,significantly higher than that in the inactive group (10.7％,3/28,P ＜ 0.05).Conclusions Anti-Smith antibodies are not only an important indicator for the diagnosis of SLE,but also a risk factor for disease exacerbation and kidney injury in children with SLE.
